miR-25-3p Modulates Tumor Aggressiveness and Ferroptosis Escape in T24 Bladder Cancer Cells In Vitro

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Urothelial bladder carcinoma (UBC) is a prevalent malignancy with ongoing efforts to find prognostic molecular markers.
• MicroRNAs (miRNAs) are emerging as promising biomarkers for cancer diagnosis and treatment.
• The role of miR-25-3p in UBC is underexplored, despite its association with other cancers.

Purpose of the Study:

• To investigate the effects of miR-25-3p modulation on high-grade, muscle-invasive bladder cancer (MIBC) cells.
• To explore the molecular targets and pathways influenced by miR-25-3p in T24 bladder cancer cells.

Main Methods:

• Bioinformatics analysis of TCGA-BLCA datasets to assess miR-25-3p expression.
• In vitro functional assays using T24 MIBC cell line with miR-25-3p mimic and inhibitor transfections.
• Gene expression analysis to identify downstream targets and affected pathways.

Main Results:

• miR-25-3p was found to be upregulated in UBC tumor tissues.
• miR-25-3p overexpression enhanced cell proliferation, viability, and migration in T24 cells.
• miR-25-3p inhibition decreased cell migration capacity and modulated expression of genes involved in oxidative stress and ferroptosis.

Conclusions:

• Modulation of miR-25-3p significantly impacts the behavior of T24 bladder cancer cells, promoting a more aggressive phenotype.
• miR-25-3p influences pathways related to oxidative stress and cell death, suggesting a role in bladder cancer progression.
• miR-25-3p shows potential as a prognostic biomarker and therapeutic target for high-grade and muscle-invasive bladder cancer.